Cargando…

Implementing telemedicine in inflammatory bowel disease: Is COVID-19 the definitive trigger?

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Del Hoyo, Javier, Aguas, Mariam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier España, S.L.U. 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669245/ http://dx.doi.org/10.1016/j.gastre.2020.09.001

Ejemplares similares

Implementing telemedicine in inflammatory bowel disease: Is COVID-19 the definitive trigger?
por: Del Hoyo, Javier, et al.
Publicado: (2020)

Are we ready for telemonitoring inflammatory bowel disease? A review of advances, enablers, and barriers
por: Del Hoyo, Javier, et al.
Publicado: (2023)

Changes in the management of IBD patients since the onset of COVID-19 pandemic. A path toward the implementation of telemedicine in Spain?
por: del Hoyo, Javier, et al.
Publicado: (2022)

Changes in the management of IBD patients since the onset of COVID-19 pandemic. A path toward the implementation of telemedicine in Spain?
por: del Hoyo, Javier, et al.
Publicado: (2022)

A Web-Based Telemanagement System for Improving Disease Activity and Quality of Life in Patients With Complex Inflammatory Bowel Disease: Pilot Randomized Controlled Trial
por: Del Hoyo, Javier, et al.
Publicado: (2018)

A Web-Based Telemanagement System for Patients With Complex Inflammatory Bowel Disease: Protocol for a Randomized Controlled Clinical Trial
por: Aguas, Mariam, et al.
Publicado: (2018)

Adaptation of TECCU App Based on Patients´ Perceptions for the Telemonitoring of Inflammatory Bowel Disease: A Qualitative Study Using Focus Groups
por: Del Hoyo, Javier, et al.
Publicado: (2020)

Telemedicine for COVID-19()
por: Ena, J.
Publicado: (2020)

Evolution of the emotional impact in patients with early inflammatory bowel disease during and after Covid-19 lockdown
por: Sempere, Laura, et al.
Publicado: (2022)

Evolution of the emotional impact in patients with early inflammatory bowel disease during and after Covid-19 lockdown
por: Sempere, Laura, et al.
Publicado: (2022)

Can COVID-19 Trigger De Novo Inflammatory Bowel Disease?
por: Taxonera, Carlos, et al.
Publicado: (2021)

Inflammatory Bowel Disease
por: Sachar, David B., et al.
Publicado: (2012)

Applying Telemedicine to Multidisciplinary Pediatric Inflammatory Bowel Disease Care
por: Michel, Hilary K., et al.
Publicado: (2021)

Telemedicine: A promising future for inflammatory bowel disease management
por: Fazal, Faizan, et al.
Publicado: (2022)

Innovation in Inflammatory Bowel Disease Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease
por: Lees, Charlie W., et al.
Publicado: (2020)

The impact of COVID-19 on the development and consolidation of telemedicine
por: Mariani, Alessandro Wasum, et al.
Publicado: (2021)

Telemedicine in inflammatory bowel diseases: A new brick in the medicine of the future?
por: Gravina, Antonietta Gerarda, et al.
Publicado: (2023)

The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients
por: Bastida, Guillermo, et al.
Publicado: (2010)

Bowel Preparation in Inflammatory Bowel Disease—A Necessary Evil?
por: Lightner, Amy L
Publicado: (2020)

Challenges of modern day transition care in inflammatory bowel disease: From inflammatory bowel disease to biosimilars
por: Hakizimana, Ali, et al.
Publicado: (2017)

Telemedicine, legal certainty, and COVID-19: where are we?
por: Garcia, Marcos Vinicius Fernandes, et al.
Publicado: (2020)

Use of telemedicine to combat the COVID-19 pandemic in Brazil
por: Carvalho, Carlos Roberto Ribeiro, et al.
Publicado: (2020)

Telemedicine in the COVID-19 era: a tricky transition
por: Palabindala, Venkataraman, et al.
Publicado: (2021)

Hygiene hypothesis in inflammatory bowel disease
por: Saidel-Odes, Lisa, et al.
Publicado: (2014)

Targeting lymphatics in inflammatory bowel disease
por: D'Aiessio, Silvia, et al.
Publicado: (2015)

Novel Topics in Inflammatory Bowel Disease
por: Sakuraba, Atsushi, et al.
Publicado: (2016)

Extraintestinal Manifestations of Inflammatory Bowel Disease
por: Al-Quorain, Abdulaziz A.
Publicado: (2019)

The great wall of inflammatory bowel disease
por: Al Sulais, Eman, et al.
Publicado: (2022)

Perception of the COVID-19 Pandemic Among Patients With Inflammatory Bowel Disease in the Time of Telemedicine: Cross-Sectional Questionnaire Study
por: Zingone, Fabiana, et al.
Publicado: (2020)

Inflammatory Bowel Disease: A Global Disease
por: Ghosh, Subrata, et al.
Publicado: (2013)

Transforming Access to Specialist Care for Inflammatory Bowel Disease: The PACE Telemedicine Program
por: Habashi, Peter, et al.
Publicado: (2019)

Factors to consider before implementing telemedicine protocols to manage neonatal jaundice
por: Jo, Heui Seung
Publicado: (2022)

Telemedicine in the Era of COVID-19 and Beyond: A new horizon
por: Alsaffar, Hussain, et al.
Publicado: (2020)

Neuro-Oncology Practice in 2021: Covid-19, telemedicine, and beyond
por: Roth, Patrick
Publicado: (2021)

ABC of topical therapy in inflammatory bowel disease
por: Goodsall, Thomas M, et al.
Publicado: (2020)

Inflammatory Bowel Disease and the Environment: More to Come
por: El-Matary, Wael
Publicado: (2020)

Inflammatory Bowel Disease: Changing Associations to Mechanisms
por: Click, Benjamin, et al.
Publicado: (2016)

Implementation of a Telemedicine Clinic in the Covid-19 Era
por: Khalil, Suzan, et al.
Publicado: (2020)

More room for telemedicine after COVID-19: lessons for primary care?
por: Garattini, Livio, et al.
Publicado: (2020)

Telemedicine and COVID-19: beyond just virtual consultations – the Singapore experience
por: Lai, Sean H. S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c3rohoge2jdl54j6e4stv4bj94